Amedica (AMDA) began trading on the NASDAQ on 13 February 2014

Amedica Corp. (NASDAQ: AMDA) is a medical device maker that began trading on Thursday. The IPO offered 3.5 million shares at a price of $5.75 a share, a far cry from the expected range of $10 to $12. Underwriters have a 30-day option on an additional 525,000 shares. Shares closed at $5.39 on Thursday and at $5.68 on Friday.

Description

Amedica Corporation (Amedica) is a commercial biomaterial company focused on using its silicon nitride technology platform to develop, manufacture and sell a broad range of medical devices. The Company market spinal fusion products and are developing products for use in total hip and knee joint replacements. The Company markets its Valeo family of silicon nitride interbody spinal fusion devices in the United States and Europe for use in the cervical and thoracolumbar areas of the spine. In addition to its silicon nitride-based spinal fusion products, it markets a complementary line of non-silicon nitride spinal fusion products which allows us to provide surgeons and hospitals with a broader range of products. These products include three lines of spinal fusion devices and five types of orthobiologics, which are used by surgeons to help promote bone growth and fusion in spinal fusion procedures.

Address

1885 West 2100 South
SALT LAKE CITY, UT 84119
United States 

Website 

http://www.amedicacorp.com

Key stats and ratios

	Q3 (Sep '13)	2012
Net profit margin	-48.69%	-151.89%
Operating margin	-38.73%	-127.26%
EBITD margin	-	-41.44%
Return on average assets	-32.11%	-74.01%
Return on average equity	-	-
Employees	74